No Metabolic Risk for Antipsychotic-Naive Patients : compare

An Austrian study of the baseline prevalence of metabolic abnormalities and changes following treatment with five commonly-used antipsychotic drugs

Related Keywords

Austria , Austrian , , International Journal Of Neuropsychopharmacology , International Journal , European First Episode Schizophrenia ,